Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Ajanta Pharma USA Inc
483
•Ajanta Pharma USA Inc•July 22, 2025

Ajanta Pharma USA Inc – FDA 483, Jul 22, 2025

Record Details

An FDA inspection conducted between July 15 and July 22, 2025, at an undisclosed pharmaceutical firm, identified a critical deficiency in post-marketing drug surveillance. The primary observation was the complete absence of written procedures for the surveillance, receipt, evaluation, and reporting of adverse drug experiences to the FDA. Specifically, the firm lacked established protocols for managing spontaneous, foreign, and expedited individual case safety reports (ICSRs). This lapse was noted despite the firm having commercialized various drug products internationally for several years. The inspection confirmed that no ICSRs related to these products had been surveyed, processed, or reported to the FDA since their initial commercialization. This non-compliance falls under the regulatory framework of the Federal Food, Drug, and Cosmetic Act, which mandates robust post-market safety reporting to ensure public health. The firm is now required to develop and implement comprehensive written procedures for adverse event management and retrospectively address any unreported safety data to comply with federal regulations.

Company
Ajanta Pharma USA Inc
Inspection date
July 22, 2025
Product type
drugs
Office
New Jersey District Office
Person
  • Jay B. Shah (Investigator)
View Company Profile

ID · a9671d7d-1ad1-4ff0-9f93-f1f64b6d9ec7

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Ajanta Pharma USA Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.